Teva: Enjuvia may reduce nighttime awakenings in postmenopausal women

SAN FRANCISCO A branded drug made by Teva Pharmaceutical Industries reduced the frequency of nighttime awakenings due to hot flashes in postmenopausal women, according to results of a study presented Tuesday at the annual meeting of the American College of Obstetricians and Gynecologists in San Francisco.

The study was designed to evaluate the effectiveness of Teva Women’s Health’s Enjuvia (synthetic conjugated estrogens, B) in 0.3 mg and 0.625 mg doses over a 12-week period in women described as highly symptomatic, meaning the women experienced at least three awakenings per night. The researchers said Enjuvia significantly reduced nighttime awakenings among women in both treatment arms.

“Sleep disruptions due to menopausal symptoms can adversely impact a woman’s quality of life,” lead study investigator and Case Western Reserve University medical professor James Liu said. “These results are encouraging and show that highly symptomatic postmenopausal women who are repeatedly and routinely awakened by hog flashes night after night can find relief with Enjuvia even at the lowest dose to regain better control over their sleep time.”

Login or Register to post a comment.